Clinical Trial Update: Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase II trial update for Hemay005 in active ulcerative colitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Moderate to Severe Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING